Literature DB >> 11907806

Physical and functional characterization of the human LGI1 gene and its possible role in glioma development.

Dietmar Krex1, Martin Hauses, Hella Appelt, Brigitte Mohr, Gerhard Ehninger, Hans Konrad Schackert, Gabriele Schackert.   

Abstract

The human gene termed LGI1 (leucine-rich gene - glioma inactivated) has been isolated recently, and is supposed to be an additional candidate tumor suppressor gene involved in the formation and progression of glioblastoma multiforme [Chernova et al. (1998) Oncogene 17:2873-2881]. To test this hypothesis and to complete the characterization of the gene, we performed various detailed studies on the genomic structure, the mRNA expression level, the integrity of the cDNA, and retroviral gene transfer into LGI1-deficient cell lines. Two single nucleotide polymorphisms in the promotor region and a highly polymorphic intragenic microsatellite repeat between exon 4 and 5 were found. Phylogenetic sequence analysis techniques were applied, which showed functional relationships between LGI1 and TRK and SLIT protein families that are known to be involved in development and maintenance of the nervous system. Fluorescence in situ hybridization (FISH) analysis showed LGI1 to be present on 10q24 in each of 11 glioma-derived cell lines evaluated. Sequence analysis of the LGI1 transcript did not detect any mutation. Relative amounts of LGI1 mRNA copy numbers as measured by the real-time fluorescence detection LightCycler technology differed more than three orders of magnitude and were significantly reduced in 10 of 11 cell lines. Retroviral gene transfer into LGI1-deficient glioma-derived cell lines could not substantiate any difference to control infected cultures regarding growth rate, S phase transition, and maintenance of marker gene expression. The strong homology to proteins involved in development, differentiation, or maintenance of the nervous system provides evidence for a function of the LGI1 protein in neural tissue. The observation that translocation or deletion of the LGI1 locus or mutation of the coding sequence of the LGI1 mRNA is not a frequent event in malignant glioma cell lines suggests that epigenetic factors lead to substantial differences in the amount of LGI1 mRNA expression. In addition, that the effect is lacking after retroviral gene transfer in cell culture suggests that binding of some kind of a ligand is essential for its biological activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11907806     DOI: 10.1007/s004010100463

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

Review 1.  LGI1: a gene involved in epileptogenesis and glioma progression?

Authors:  W Gu; E Brodtkorb; T Piepoli; G Finocchiaro; O K Steinlein
Journal:  Neurogenetics       Date:  2005-04-13       Impact factor: 2.660

Review 2.  The LGI1 protein: molecular structure, physiological functions and disruption-related seizures.

Authors:  Paul Baudin; Louis Cousyn; Vincent Navarro
Journal:  Cell Mol Life Sci       Date:  2021-12-30       Impact factor: 9.261

3.  Inactivation of LGI1 expression accompanies early stage hyperplasia of prostate epithelium in the TRAMP murine model of prostate cancer.

Authors:  John K Cowell; Karen Head; Padmaja Kunapuli; Mary Vaughan; Ellen Karasik; Barbara Foster
Journal:  Exp Mol Pathol       Date:  2009-09-22       Impact factor: 3.362

4.  Expression profile of Lgi1 gene in mouse brain during development.

Authors:  Patrícia A O Ribeiro; Lourenço Sbragia; Rovilson Gilioli; Francesco Langone; Fábio F Conte; Iscia Lopes-Cendes
Journal:  J Mol Neurosci       Date:  2008-06-18       Impact factor: 3.444

5.  Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1.

Authors:  Tiziana Piepoli; Cemile Jakupoglu; Wenli Gu; Elena Lualdi; Blanca Suarez-Merino; Pietro L Poliani; Maria Grazia Cattaneo; Barbara Ortino; Dorota Goplen; Jian Wang; Rosa Mola; Francesca Inverardi; Carolina Frassoni; Rolf Bjerkvig; Ortrud Steinlein; Lucia M Vicentini; Oliver Brüstle; Gaetano Finocchiaro
Journal:  Neuro Oncol       Date:  2006-03-02       Impact factor: 12.300

6.  Somatic alterations in brain tumors.

Authors:  Jill Barnholtz-Sloan; Andrew E Sloan; Susan Land; William Kupsky; Alvaro N A Monteiro
Journal:  Oncol Rep       Date:  2008-07       Impact factor: 3.906

7.  Expression of the LGI1 gene product in astrocytic gliomas: downregulation with malignant progression.

Authors:  Razvan Besleaga; Manuel Montesinos-Rongen; Jordi Perez-Tur; Reiner Siebert; Martina Deckert
Journal:  Virchows Arch       Date:  2003-08-26       Impact factor: 4.064

8.  Defining the expression pattern of the LGI1 gene in BAC transgenic mice.

Authors:  Karen Head; Shiaoching Gong; Sheldon Joseph; Cuidong Wang; Tania Burkhardt; Michael R Rossi; Jeffrey LaDuca; Sei-Ichi Matsui; Mary Vaughan; David G Hicks; Nathaniel Heintz; John K Cowell
Journal:  Mamm Genome       Date:  2007-06-13       Impact factor: 2.957

9.  Leucine-rich glioma inactivated 3 induces neurite outgrowth through Akt and focal adhesion kinase.

Authors:  Woo-Jae Park; Yun Young Lim; Nyoun Soo Kwon; Kwang Jin Baek; Dong-Seok Kim; Hye-Young Yun
Journal:  Neurochem Res       Date:  2010-02-17       Impact factor: 3.996

Review 10.  LGI proteins in the nervous system.

Authors:  Linde Kegel; Eerik Aunin; Dies Meijer; John R Bermingham
Journal:  ASN Neuro       Date:  2013-06-25       Impact factor: 4.146

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.